DK457176A - Fremgangsmade til fremstilling af blokerede cholecalciferol-forbindelser - Google Patents

Fremgangsmade til fremstilling af blokerede cholecalciferol-forbindelser

Info

Publication number
DK457176A
DK457176A DK457176A DK457176A DK457176A DK 457176 A DK457176 A DK 457176A DK 457176 A DK457176 A DK 457176A DK 457176 A DK457176 A DK 457176A DK 457176 A DK457176 A DK 457176A
Authority
DK
Denmark
Prior art keywords
blocked
procedure
preparation
cholecalciferol compounds
cholecalciferol
Prior art date
Application number
DK457176A
Other languages
Danish (da)
English (en)
Inventor
D P Jacobus
H Jones
S S Yang
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK457176A publication Critical patent/DK457176A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK457176A 1975-10-14 1976-10-12 Fremgangsmade til fremstilling af blokerede cholecalciferol-forbindelser DK457176A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62197675A 1975-10-14 1975-10-14

Publications (1)

Publication Number Publication Date
DK457176A true DK457176A (da) 1977-04-15

Family

ID=24492438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457176A DK457176A (da) 1975-10-14 1976-10-12 Fremgangsmade til fremstilling af blokerede cholecalciferol-forbindelser

Country Status (12)

Country Link
US (1) US4069321A (es)
JP (1) JPS5268163A (es)
AU (1) AU1842976A (es)
BE (1) BE847223A (es)
DE (1) DE2646240A1 (es)
DK (1) DK457176A (es)
ES (1) ES452198A1 (es)
FR (1) FR2327790A1 (es)
GB (1) GB1524418A (es)
NL (1) NL7611274A (es)
SE (1) SE7611261L (es)
ZA (1) ZA766097B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147051A (en) * 1977-05-24 1978-12-21 Teijin Ltd 1alpha-hydroxy-24-dehydro-vitamin d3 and its preparation
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof
US4224230A (en) * 1978-07-26 1980-09-23 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4263214A (en) * 1978-07-26 1981-04-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4229357A (en) * 1978-07-26 1980-10-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
US4196133A (en) * 1979-03-05 1980-04-01 Wisconsin Alumni Research Foundation 24,24-Difluoro-25-hydroxycholecalciferol
US4201881A (en) * 1979-03-28 1980-05-06 Wisconsin Alumni Research Foundation 24,24-Difluoro-1α,25-dihydroxycholecalciferol
US4230626A (en) * 1979-07-30 1980-10-28 G. D. Searle & Co. 25-Halocholest-5-ene-3β,22-diols and esters thereof
US4230627A (en) * 1979-08-06 1980-10-28 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
US4287129A (en) * 1980-07-28 1981-09-01 Diamond Shamrock Corp. Synthesis of 1α-hydroxy-7-dehydrosteroids
ATE19623T1 (de) * 1981-07-17 1986-05-15 Duphar Int Res Verfahren zur herstellung von 1-alpha-hydroxy vitamin d oder 1-alpha hydroxy previtamin d derivaten und previtamin d oder tachysteroladdukten mit geeigneten dienophilen.
US4634692A (en) * 1981-08-28 1987-01-06 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxy-24R-fluorocholecalciferol and 1α,25-dihydroxy-24S-fluorocholecalciferol
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
DE3565401D1 (de) * 1984-02-08 1988-11-10 Hoffmann La Roche Calciferol derivatives
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
US4929609A (en) * 1987-03-12 1990-05-29 Hoffmann-La Roche Inc. 25, 28-dihydroxyergocalciferol and 1,25,28-trihydroxyergocalciferol compositions thereof and their use in the treatment of hyperproliferative disease
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
WO1993021205A1 (en) * 1992-04-15 1993-10-28 Sri International Isolation of steroids containing a 5,7-diene functionality from a sterol mixture
JP2905091B2 (ja) * 1994-06-24 1999-06-14 日本バルカー工業株式会社 フッ素樹脂被覆ガスケットの製造方法
KR100756823B1 (ko) * 2001-10-23 2007-09-07 주식회사 엘지생활건강 신규한 폴리에톡실화 콜레칼시페롤 유도체 및 그의 제조방법
WO2007095161A2 (en) * 2006-02-14 2007-08-23 New York University Methods and compositions for treating disorders associated with increased bone turnover and osteopenia
CA3136914A1 (en) * 2019-05-09 2020-11-12 Fermenta Biotech Limited Novel method for synthesizing 25-oh cholesterol/calcifediol from phytosterol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862934A (en) * 1955-06-14 1958-12-02 Philips Corp Method of producing tachysterol and dihydrotachysterol
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3607888A (en) * 1969-08-07 1971-09-21 Wisconsin Alumni Res Found 25-hydroxytachysterol3 25-hydroxydihydrotachysterol3 and methods for preparing same

Also Published As

Publication number Publication date
ZA766097B (en) 1978-05-30
JPS5268163A (en) 1977-06-06
SE7611261L (sv) 1977-04-15
US4069321A (en) 1978-01-17
BE847223A (fr) 1977-04-13
AU1842976A (en) 1978-04-13
DE2646240A1 (de) 1977-04-28
ES452198A1 (es) 1977-12-16
GB1524418A (en) 1978-09-13
FR2327790B1 (es) 1979-07-20
FR2327790A1 (fr) 1977-05-13
NL7611274A (nl) 1977-04-18

Similar Documents

Publication Publication Date Title
DK457176A (da) Fremgangsmade til fremstilling af blokerede cholecalciferol-forbindelser
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
DK451076A (da) Fremgangsmade til fremstilling af 2-azetidinonforbindelser
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK457576A (da) Fremgangsmade til fremstilling af antibakterielle midler
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK227276A (da) Fremgangsmade til fremstilling af olieabsorberende materialer
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK99376A (da) Fremgangsmade til fremstilling af lavalkylimidazolcarboxylater
DK484676A (da) Fremgangsmade til fremstilling af aroyl-phenyliden- eller aroyl-phenylnaphthalenforbindelser
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK123177A (da) Fremgangsmade til fremstilling af 7-alkoxy-3-chlormethyl-3-cephem-forbindelser
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner
DK155008C (da) Fremgangsmaade til fremstilling af 3-methylencepham-forbindelser